Body Fluid Supernatants Contain Sufficient Cell-Free DNA for Targeted Next Generation Sequencing

被引：0
|
作者：
Akagi, Naomi [1 ]
Ruiz-Cordero, Roberto [2 ]
Ng, Dianna [3 ]
Menke, Joshua
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Pathol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
324
引用
收藏
页码：319 / 320
页数：2
相关论文
共 50 条
  • [41] Capnocytophaga canimorsus meningitis diagnosed using next- generation sequencing of microbial cell-free DNA
    Asif, Abuzar A.
    Roy, Moni
    Tellier, Benjamin R.
    Ahmad, Sharjeel
    IDCASES, 2021, 24
  • [42] Detection of cell-free DNA in bronchial lavage fluid supernatants of patients with lung cancer
    Carstensen, T
    Schmidt, B
    Engel, E
    Jandrig, B
    Witt, C
    Fleischhacker, M
    CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS, 2004, 1022 : 202 - 210
  • [43] Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia
    Benamu, Esther
    Gajurel, Kiran
    Anderson, Jill N.
    Lieb, Tullia
    Gomez, Carlos A.
    Seng, Hon
    Aquino, Romielle
    Hollemon, Desiree
    Hong, David K.
    Blauwkamp, Timothy A.
    Kertesz, Mickey
    Blair, Lily
    Bollyky, Paul L.
    Medeiros, Bruno C.
    Coutre, Steven
    Zompi, Simona
    Montoya, Jose G.
    Deresinski, Stan
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (09) : 1659 - 1668
  • [44] Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA
    Supplee, Julianna G.
    Milan, Marina S. D.
    Lim, Lee P.
    Potts, Kristy T.
    Sholl, Lynette M.
    Oxnard, Geoffrey R.
    Paweletz, Cloud P.
    LUNG CANCER, 2019, 134 : 96 - 99
  • [45] Genetic Profiling of Circulating Free DNA in Glioma by Targeted Next Generation Sequencing
    Husain, Nuzhat
    Mishra, Sridhar
    Husain, Adil
    Kaif, Mohammad
    Awale, Rupali
    Shukla, Saumya
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1610 - 1611
  • [46] Genetic Profiling of Circulating Free DNA in Glioma by Targeted Next Generation Sequencing
    Husain, Nuzhat
    Mishra, Sridhar
    Husain, Adil
    Kaif, Mohammad
    Awale, Rupali
    Shukla, Saumya
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1610 - 1611
  • [47] Targeted next generation sequencing (NGS) of cell free (cf) DNA in biliary tract cancer (BTC)
    Cowzer, D.
    Seier, K.
    Darmofal, M.
    Shin, P.
    Khalil, D.
    Walch, H.
    Shia, J.
    Park, W.
    Eldika, I.
    Chatila, W.
    Schultz, N.
    Wei, A.
    Cercek, A.
    O'Reilly, E. M.
    Solit, D.
    Gonen, M.
    Berger, M.
    Abou-Alfa, G. K.
    Jarnagin, W.
    Harding, J. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S133 - S133
  • [48] Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation
    Khush, Kiran K.
    De Vlaminck, Iwijn
    Luikart, Helen
    Ross, David J.
    Nicolls, Mark R.
    ERJ OPEN RESEARCH, 2021, 7 (01) : 1 - 8
  • [49] Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
    Helman, Elena
    Minh Nguyen
    Karlovich, Chris A.
    Despain, Darrin
    Choquette, A. Karin
    Spira, Alexander, I
    Yu, Helena A.
    Camidge, D. Ross
    Harding, Thomas C.
    Lanman, Richard B.
    Simmons, Andrew D.
    CLINICAL LUNG CANCER, 2018, 19 (06) : 518 - +
  • [50] Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma
    Bessi, Lucile
    Viailly, Pierre-Julien
    Bohers, Elodie
    Ruminy, Philippe
    Maingonnat, Catherine
    Bertrand, Philippe
    Vasseur, NasrinSarafan
    Beaussire, Ludivine
    Cornic, Marie
    Etancelin, Pascaline
    Camus, Vincent
    Picquenot, Jean-Michel
    Tilly, Herve
    Stamatoullas, Aspasia
    Jardin, Fabrice
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 498 - 502
12345